Intel employee Bryce Olson was diagnosed with stage 4 prostate cancer. When the standard of care didn't work, Bryce turned to genomic sequencing which allowed his doctors to identify specific genetic drivers of his disease and identify specific treatments and clinical trials that were a fit for his specific cancer. This precision medicine approach helped send his cancer into remission for several years.

Now that his cancer has returned, Bryce is working with the Broad Institute and other leaders in the field of advanced cancer research to use artificial intelligence powered by Intel technology to discover new, innovative solutions that can help him and millions of others like him around the world.

This video was produced in partnership with Intel.

Learn more about the work Intel is doing to power the future of healthcare intelligence at intel.com/healthcare

For more stories profiling pioneers of science and tech innovation, subscribe to Freethink at    / freethinkmedia  

And follow Freethink across other platforms here:

Facebook:   / freethinkmedia  
Twitter:   / freethinkmedia  
Instagram:   / freethinkmedia  
Website: http://www.freethink.com